IL17A and COVID-19: Treatments at the onset of COVID-19, n (%)– Prednisone– Prednisone dose (mg/day)– Conventional DMARDS– Methotrexate– Hydroxychloroquine– TNF inhibitors– Leflunomide– Anti-CD20– Anti-IL17– Sulfasalazine– Azathioprine– Baricitinib– Abatacept– Calcineurin inhibitors– Anti-IL1– Tofactinib– Upadacitinib– Mycophenolate mophetil– Anti-IL6